In a study published April 12 in the journal PLoS Pathogens, the scientists demonstrated for the first time that engineering stem cells to form immune cells targeting HIV is effective in suppressing the virus in living tissues in an animal model.
You are here
Coverage of the latest news and updates from ongoing clinical trials from various sources.
Board president Dr. Irwin Zeitler told the Houston Chronicle that the board made the move in response to the federal government's sluggishness in sanctioning stem cell therapies.
Njemanze said in an interview he was concerned that if the bill passes, impoverished Nigerian women will sell their eggs to IVF clinics funded by entities outside the country, which would then illegitimately export them for sale in the international market.
At Morehouse, Gibbons, 55, founded and directs a cardiovascular research institute focused on areas including basic science to ethnic disparities in health. Gibbons' own lab studies how genetic variation influences vascular biology and cardiovascular disease.
The molecule, called kartogenin, was tested on mice suffering from joint problems. Many of the mice treated regained their ability to use their damaged joints and appeared pain-free.
By introducing the cultures to this particular bioreactor process, the stem cells were grown in suspension, eliminating the problems inherent in growing the cells on surfaces—something the two say has never before been accomplished.
The agreement with Brazil was signed on March 26 by CIRM President Alan Trounson and Glaucius Oliva, president of Brazil's National Council for Scientific Technological Development.
"I think the only interpretation is that we are being censored," Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco, said in a statement. "It is very disappointing that they are unwilling to hear the truth."
The new reprogramming method, published in the current edition of Cell Stem Cell, builds on work by Japanese researcher Shinya Yamanaka and his team, who produced stem cells from the connective tissue cells of mice for the first time in 2006.
On March 19, Red underwent stem cell regenerative therapy at Burke Animal Clinic in Burke, Virginia (US).